Method for producing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives

Details for Australian Patent Application No. 2004295056 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Gouraud, Yves; Rieke-Zapp, Joerg; Huang, Bao-Guo; Hanna, Reda; Schubert, Gerrit; Wu, Xiao-Dong; Keil, Johannes; Kleemann, Heinz-Werner

Agent Watermark

Pub. Number AU-B-2004295056

PCT Pub. Number WO2005/054195

Priority 103 56 717.8 02.12.03 DE

Filing date 19 November 2004

Wipo publication date 16 June 2005

Acceptance publication date 14 April 2011

International Classifications

C07C 233/66 (2006.01) Carboxylic acid amides

C07D 209/46 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/054195 Priority application(s): WO2005/054195

14 April 2011 Application Accepted

  Published as AU-B-2004295056

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295057-7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(ADP-ribose) polymerase inhibitors

2004295052-Capsule with foam conditioning feature